Tuberculosis in children: Difference between revisions
Line 28: | Line 28: | ||
===Screening in Children with HIV=== | ===Screening in Children with HIV=== | ||
<small><small>Algorithm adapted from Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children<ref name="WHO TB Children"> {{cite web |url=http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748_eng.pdf| title=WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2014}} </ref></small></small> | <small><small>Algorithm adapted from Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children<ref name="WHO TB Children"> {{cite web |url=http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748_eng.pdf| title=WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2014}} </ref></small></small><br> | ||
<small> '''IPT:''' Isoniazid preventive therapy (INH 10 mg/kg/d x 6 months)</small> | |||
<div style=" font-size: 95%;"> | <div style=" font-size: 95%;"> | ||
{{Family tree/start}} | {{Family tree/start}} | ||
Line 41: | Line 42: | ||
{{family tree |boxstyle = border-radius: 5px 5px 5px 5px;| | | | B01 | | | | | | | | | | B02 | | | | |B01=<div style="float: left; text-align: center; line-height: 150%; width: 12em">'''Yes'''</div>| B02=<div style="float: left; text-align: center; line-height: 150%; width: 12em"> '''No''' </div> }} | {{family tree |boxstyle = border-radius: 5px 5px 5px 5px;| | | | B01 | | | | | | | | | | B02 | | | | |B01=<div style="float: left; text-align: center; line-height: 150%; width: 12em">'''Yes'''</div>| B02=<div style="float: left; text-align: center; line-height: 150%; width: 12em"> '''No''' </div> }} | ||
{{family tree | | | | |!| | | | | | | | | | | |!| | | | | |}} | {{family tree | | | | |!| | | | | | | | | | | |!| | | | | |}} | ||
{{family tree |boxstyle = border-radius: 5px 5px 5px 5px;| | | | C01 | | | | | | | | | | C02 | | | | |C01=<div style="float: left; text-align: center; line-height: 150%; width: 12em">Assess for the diagnosis of TB (TST, chest X-ray, sputum studies) and rule out other diseases</div>| C02=<div style="float: left; text-align: left; line-height: 150%; width: 12em"> Does the patient has any of the following contraindications for | {{family tree |boxstyle = border-radius: 5px 5px 5px 5px;| | | | C01 | | | | | | | | | | C02 | | | | |C01=<div style="float: left; text-align: center; line-height: 150%; width: 12em">Assess for the diagnosis of TB (TST, chest X-ray, sputum studies) and rule out other diseases</div>| C02=<div style="float: left; text-align: left; line-height: 150%; width: 12em"> Does the patient has any of the following contraindications for IPT? | ||
*Active hepatitis<br> | *Active hepatitis<br> | ||
*Peripheral neuropathy<br> </div>}} | *Peripheral neuropathy<br> </div>}} |
Revision as of 16:33, 23 September 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Tuberculosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tuberculosis in children On the Web |
American Roentgen Ray Society Images of Tuberculosis in children |
Risk calculators and risk factors for Tuberculosis in children |
Overview
Tuberculosis in Children
Symptom-based Screening Approach
Algorithm adapted from Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children[1]
Child in close contact with confirmed tuberculosis case | |||||||||||||||||||||||||||||||||||||||||||||||||
< 5 yrs old | > 5 yrs old | ||||||||||||||||||||||||||||||||||||||||||||||||
Asymptomatic | Symptomatic | Symptomatic | Asymptomatic | ||||||||||||||||||||||||||||||||||||||||||||||
Administer INH 10 mg/kg/d x 6 months | No preventive treatment is recommended. | ||||||||||||||||||||||||||||||||||||||||||||||||
If the child develops symptoms | If the child develops symptoms | ||||||||||||||||||||||||||||||||||||||||||||||||
Confirm the diagnosis of TB with:
| |||||||||||||||||||||||||||||||||||||||||||||||||
Screening in Children with HIV
Algorithm adapted from Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children[1]
IPT: Isoniazid preventive therapy (INH 10 mg/kg/d x 6 months)
Child with HIV and older than 1 year | |||||||||||||||||||||||||||||||||||||||||||||||||||
Does the patient has any of the following symptoms?
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||
Assess for the diagnosis of TB (TST, chest X-ray, sputum studies) and rule out other diseases | Does the patient has any of the following contraindications for IPT?
| ||||||||||||||||||||||||||||||||||||||||||||||||||
TB confirmed | TB ruled out, other diagnosis confirmed | Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||
Administer 2HRZE/4HR regimen | Give appropriate treatment for the disease and consider IPT | Do not administer IPT | Administer IPT | ||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic Algorithm
Treatment Regimens
Tuberculosis in Children ▸ Drug Susceptible TB Regimen ▸ MDR-TB ▸ XDR-TB |
|